Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Resnick

Showing results (251-260 of 276) with videos related to

Pageof 28
Sort By:
Urological Research|February 16, 2006
Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosisSusan Ruth Marengo, Daniel H-C Chen, Andrew P Evan, et al.
American Journal of Clinical Oncology|October 1, 1985
Cytotoxic chemotherapy and androgen priming in patients with advanced carcinoma of the prostate. A phase II trial of the Piedmont Oncology AssociationH B Muss, D Case, M R Cooper, et al.
Brachytherapy|April 6, 2004
Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Bruce Sodee, et al.
JAMA|April 22, 1992
The effect of digital rectal examination on prostate-specific antigen levelsE D Crawford, M J Schutz, S Clejan, et al.
Brachytherapy|April 17, 2007
Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusionRodney J Ellis, Hang Zhou, Deborah A Kaminsky, et al.
Cancer|April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trialH B Muss, V Howard, F Richards, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 5, 1999
Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndromeS Lacroix-Desmazes, I Resnick, D Stahl, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Radioimmunoguided imaging of prostate cancer foci with histopathological correlationR J Ellis, E Y Kim, R Conant, et al.
Brachytherapy|February 8, 2007
Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetideRodney J Ellis, Hang Zhou, Edward Y Kim, et al.
Cancer|August 11, 1991
Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasiaR R Rackley, B Yang, T G Pretlow, et al.
Pageof 28

Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
Urological Research|February 16, 2006
Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosisSusan Ruth Marengo, Daniel H-C Chen, Andrew P Evan, et al.
American Journal of Clinical Oncology|October 1, 1985
Cytotoxic chemotherapy and androgen priming in patients with advanced carcinoma of the prostate. A phase II trial of the Piedmont Oncology AssociationH B Muss, D Case, M R Cooper, et al.
Brachytherapy|April 6, 2004
Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Bruce Sodee, et al.
JAMA|April 22, 1992
The effect of digital rectal examination on prostate-specific antigen levelsE D Crawford, M J Schutz, S Clejan, et al.
Brachytherapy|April 17, 2007
Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusionRodney J Ellis, Hang Zhou, Deborah A Kaminsky, et al.
Cancer|April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trialH B Muss, V Howard, F Richards, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 5, 1999
Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndromeS Lacroix-Desmazes, I Resnick, D Stahl, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Radioimmunoguided imaging of prostate cancer foci with histopathological correlationR J Ellis, E Y Kim, R Conant, et al.
Brachytherapy|February 8, 2007
Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetideRodney J Ellis, Hang Zhou, Edward Y Kim, et al.
Cancer|August 11, 1991
Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasiaR R Rackley, B Yang, T G Pretlow, et al.
Pageof 28